Market Research Logo

Brazil Pharmaceuticals & Healthcare Q1 2019

Brazil Pharmaceuticals & Healthcare Q1 2019

Key View:

The Brazilian pharmaceutical market has markedly declined in recent years due to the country's recession, limitingmultinational drugmaker appetite. Despite a slight recovery in 2017, Brazil will remain a highly challenging market. A restriction onpublic healthcare expenditure will place additional pressures on medicine prices while schemes to control prices and boost localcapacity will further dissuade foreign investment. Of the four BRICs markets, Brazil represents the worst growth prospect, althoughwe highlight that the implementation of health technology assessment indicates an improving regulatory outlook for drugmakers.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
Brazil Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Aché
Cristália
EMS
Eurofarma
GlaxoSmithKline
Medley
MSD
Novartis
Pfizer
Roche
Sanofi
Brazil Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report